Xspray Pharma
Develops improved cancer drugs (PKIs) using patented tech to circumvent secondary patents.
XSPRAY | ST
Overview
Corporate Details
- ISIN(s):
- SE0009973563 (+3 more)
- LEI:
- 549300NGRQCNZ3X4L157
- Country:
- Sweden
- Address:
- Scheeles väg 2, 171 65 Solna
- Website:
- https://xspraypharma.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Xspray Pharma is a pharmaceutical company that uses its innovative, patented HyNap technology to develop improved versions of marketed cancer drugs, primarily focusing on protein kinase inhibitors (PKIs). The company's core technology creates amorphous product candidates, which allows it to circumvent the secondary patents of original drugs that are often based on crystalline forms. This strategy enables a unique market entry pathway as soon as the original drug substance patents expire. Xspray Pharma's product candidates, such as its lead product Dasynoc, are designed to retain profile advantages that are beneficial for patients, even compared to generics that replicate the original drug. The technology is reproducible, aiming to reduce development time for future products in its pipeline.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-10-10 10:00 |
Board/Management Information
Xspray Pharmas valberedning inför årsstämman 2026
|
Swedish | 44.7 KB | ||
| 2025-10-10 10:00 |
Board/Management Information
Xspray Pharma’s Nomination Committee for the Annual General Meeting 2026
|
English | 44.5 KB | ||
| 2025-10-08 02:40 |
Legal Proceedings Report
Xspray Pharma uppdaterar om FDA-processen för Dasynoc – anmärkningar hos kontra…
|
Swedish | 45.4 KB | ||
| 2025-10-08 02:40 |
Legal Proceedings Report
Xspray Pharma provides update on the FDA process for Dasynoc – observations at …
|
English | 45.1 KB | ||
| 2025-09-30 15:55 |
Share Issue/Capital Change
Nytt antal aktier och röster i Xspray Pharma efter nyemission
|
Swedish | 42.5 KB | ||
| 2025-09-30 15:55 |
Declaration of Voting Results & Voting Rights Announcements
New number of shares and votes in Xspray Pharma after new share issue
|
English | 42.2 KB | ||
| 2025-09-11 08:00 |
Share Issue/Capital Change
Xsprays företrädesemission övertecknad –övertilldelningsemission utökad och ful…
|
Swedish | 62.2 KB | ||
| 2025-09-11 08:00 |
Share Issue/Capital Change
Xspray’s rights issue oversubscribed – over-allotment issue increased and fully…
|
English | 62.2 KB | ||
| 2025-08-26 13:10 |
Share Issue/Capital Change
Första dag för handel i teckningsrätter och BTAs flyttad till 27 augusti
|
Swedish | 57.3 KB | ||
| 2025-08-26 13:10 |
Share Issue/Capital Change
First day of trading in subscription rights and BTAs moved to August 27
|
English | 56.6 KB | ||
| 2025-08-25 16:55 |
Share Issue/Capital Change
Xspray publishes disclosure document regarding rights issue
|
English | 58.3 KB | ||
| 2025-08-25 16:55 |
Share Issue/Capital Change
Xspray offentliggör informationsdokument avseende företrädesemission
|
Swedish | 58.6 KB | ||
| 2025-08-25 16:45 |
Share Issue/Capital Change
Xspray receives additional subscription undertakings of SEK 20 million in the o…
|
English | 60.6 KB | ||
| 2025-08-25 16:45 |
Share Issue/Capital Change
Xspray erhåller ytterligare teckningsåtaganden om 20 MSEK i den pågående företr…
|
Swedish | 61.1 KB | ||
| 2025-08-15 08:00 |
Interim Report
|
Swedish | 1018.3 KB |
Automate Your Workflow. Get a real-time feed of all Xspray Pharma filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Xspray Pharma via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-01-17 | Anders Bladh | Other | Buy | 28,006 | 980,770.12 SEK |
| 2024-01-16 | Anders Bladh | Other | Buy | 31,994 | 1,126,828.68 SEK |
| 2023-11-30 | Torbjörn Koivisto | Other | Other | 1,000 | 40,000.00 SEK |
| 2023-11-30 | Anders Bladh | Other | Other | 300,000 | 12,000,000.00 SEK |
| 2023-11-30 | Anders Bladh | Other | Other | 1,628 | 65,120.00 SEK |
| 2023-11-30 | Anders Bladh | Other | Other | 24,145 | 965,800.00 EUR |
| 2023-11-27 | Anders Bladh | Other | Buy | 5,000 | 198,650.00 SEK |
| 2023-11-21 | Anders Bladh | Other | Buy | 10,000 | 395,000.00 SEK |
| 2023-11-20 | Anders Bladh | Other | Buy | 10,000 | 394,900.00 SEK |
| 2023-11-15 | Anders Bladh | Other | Buy | 10,000 | 390,200.00 SEK |
